High dose astaxanthin lowers blood pressure and increases insulin sensi-tivity in rats: Are these effects interdependent?

International Journal of Medical Sciences

Volumn 8, Issue 2, 2011, Pages 126-138

  Preuss, Harry G ^a   Echard, Bobby ^a   Yamashita, Eiji ^b   Perricone, Nicholas V ^c  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b FUJI CHEMICAL INDUSTRIES LTD   (Japan)

^c MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Astaxanthin; Bp effect; Insulin resistance; Renin angiotensin system; Restraint stress

Indexed keywords

ASTAXANTHIN; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; GLUCOSE; INSULIN; LOSARTAN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PIOGLITAZONE; SUCROSE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; DRUG DOSE INCREASE; DRUG MECHANISM; DRUG MEGADOSE; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; IMMOBILIZATION STRESS; INSULIN METABOLISM; INSULIN RESISTANCE; INSULIN SENSITIVITY; LOW DRUG DOSE; MALE; NONHUMAN; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SPRAGUE DAWLEY RAT; SYSTOLIC BLOOD PRESSURE; ZUCKER DIABETIC FATTY RAT;

EID: 79951782426     PISSN: None     EISSN: 14491907     Source Type: Journal    
DOI: 10.7150/ijms.8.126     Document Type: Article

References (35)

1. Preuss HG, Echard B, Bagchi D, et al. Astaxanthin lowers blood pressure and lessens activity of the renin-angiotensin system in Zucker Fatty Rats. J Functional Foods 2009; 1: 13-22.
2. Zucker LM, Zucker TF. Fatty, a new mutation in the rat. J Hered 1961; 52: 275-8.
3. Bray GA. The Zucker-fatty rat: a review. Fed Proc 1977; 36: 148-53.
4. Bach A, Schirardin H, Bauer M, et al. Age-related changes in biological parameters in Zucker rats. Lipids 1981; 16: 841-8.
5. Hussein G, Nakagawa T, Goto H, et al. Astaxanthin ameliorates features of metabolic syndrome in SHR/NDmcr-cp. Life Sci 2007; 80: 522-9.
6. Reaven GM. The individual components of the metabolic syn-drome: is there a raison d'etre? J Amer Coll Nutr 2007; 26: 191-5.
7. Jornayvez FR, Samuel VT, Shulman GI. The role of muscle insulin resistance in the pathogenesis of atherogenic dyslipidemia and non alcoholic liver disease associated with the metabolic syndrome. Annual Rev Nutr 2010; 30: 273-90.
8. Bunag RD: Validation in awake rats of a tail-cuff method measuring systolic pressure. J Appl Physiol 1973; 34: 279-82.
9. Preuss MB, Preuss HG. Effects of sucrose on the blood pressure of various strains of Wistar rats. Lab Invest 1980; 43: 101-7.
10. Preuss HG, Fournier RD, Preuss J, et al. Effects of different refined carbohydrates on the blood pressure of SH and WKY Rats. J Clin Biochem and Nutr 1988; 5: 9-20.
11. Perricone NV, Bagchi D, Echard B, Preuss HG. Blood pressure lowering effects of niacin-bound chromium in sucrose-fed rats: renin-angiotensin system. J Inorganic Biochem 2008; 102: 1541-8.
12. Turner RC, Holman RR, Matthews D, et al. Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations. Metabolism 1979; 28: 1086-96.
13. Wong PC, Price WA Jr, Chiu AT, et al. In vivo pharmacology of DuP 753. Am J Hypertens 1991; 4 (Suppl): 288s-98s.
14. Mohamadi A, Jarrell ST, Dadgar-Dehkordi A, et al. Effects of wild garlic on blood pressure and other parameters of hyper-tensive rats: comparison with cultivated garlics. Heart Disease 2000; 2: 3-9.
15. M, Dornfeld L. Pomegranate juice consumption inhib-its serum angiotensin converting enzyme activity and reduces systolic blood pressure. Atherosclerosis 2001; 158: 195-8.
16. Dunnett C. A multiple comparison procedure for comparing several treatments with control. J Am Statis Assoc 1955; 50: 1096-121.
17. Hussein G, Sankawa U, Goto H, et al. Astaxanthin, a carotenoid with potential in human health and nutrition. J Nat Prod 2006; 69: 443-9.
18. Torrissen OJ, Hardy RW, Shearer KD. Pigmentation of salm-onids -- carotenoid deposition and metabolism. CRC Crit Rev Aquat Sci 2000; 1: 209-25.
19. Naguib Y. Pioneering astaxanthin. Nutrition Science News 2001;:1-6.
20. Goto S, Kogure K, Abe K, et al. Efficient radical trapping at the surface and inside the phospholipid membrane is responsible for highly potent antiperoxidative activity of the carotenoid astaxanthin. Biochim and Biophy Acta 2001; 1512: 251-8.
21. Preuss H. The insulin system: influence of antioxidants. J Ameri Coll of Nutr (Editorial) 1998; 17: 101-2.
22. Preuss HG, Fournier RD. Effects of sucrose ingestion on blood pressure. Life Sci 1982; 30: 878-86.
23. More NS, Rao NA, Preuss HG. Early sucrose-induced retinal vascular lesions in SHR and WKY rats. Ann Lab Clin Sci 1986; 16: 419-26.
24. Reaven GM, Ho H, Hoffman BB. Attenuation of fruc-tose-induced hypertension in rats by exercise training. Hyper-tension 1988; 12: 129-32.
25. Preuss HG, Gondal JA, Bustos E, et al. Effect of chromium and guar on sugar-induced hypertension in rats. Clin Neph 1995; 44: 170-7.
26. Mertz W. Chromium in human nutrition: a review. J Nutr 1993; 123: 626-33.
27. Anderson RA. Recent advances in the clinical and biochemical effects of chromium deficiency. Essential and toxic trace ele-ments in human health and disease: an update. New York: Wiley-Liss, Inc. 1993: 221-34.
28. Freireich EJ, Gehan EA, Rall DP et al. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemotherapy Reports 1966; 50: 219-44.
29. Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB Journal 2008; 22: 659-61.
30. Scheen AJ. Prevention of type 2 diabetes mellitus through inhi-bition of the renin-angiotensin system. Drugs 2004; 64: 2537-65.
31. Lam HC, Lee JK, Chiang HT, et al. Is captopril-induced im-provement of insulin sensitivity mediated via endothelin. J Cardiovasc Pharmacol 1998; 31(Suppl 1): S496-500.
32. Buchanan TA, Meehan WP, Jeng YY, et al. Blood pressure low-ering by pioglitazone. Evidence for a direct vascular effect. J Clin Invest 1995; 96: 354-60.
33. Nishikawa Y, Minenaka Y, Ichimura M, et al. Effects of astaxanthin and vitamin C on the prevention of gastric ulcera-tion in stressed rats. J Nutr Sci Vitaminology (Tokyo) 2005; 51: 135-41.
34. It S, Ogata E, Yamada M, Showa Denko. Anti-stress agent for animals and a method of reducing stress in animals. United States patent 5937790.
35. Asami S, Yang ZB, Yamashita E, Otoze H. Anti-stress composi-tion. United States patent 6265450.